Claims for Patent: 7,632,983

Summary for Patent: 7,632,983

Title:	Expression of monoclonal antibodies in duckweed
Abstract:	Methods, nucleic acid sequences, and transformed duckweed plant or duckweed nodule cultures for the expression and the secretion of biologically active polypeptides from genetically engineered duckweed are provided. Expression of recombinant polypeptides in duckweed is improved by modifying the nucleotide sequence of the expression cassette encoding the polypeptide for improved expression in duckweed. Recovery of biologically active polypeptides from duckweed is improved by linking the biologically active polypeptide to a signal peptide that directs the secretion of the polypeptide into the culture medium. Methods of producing recombinant monoclonal antibodies having effector function, and antibodies produced by these methods are provided.
Inventor(s):	Dickey; Lynn F. (Cary, NC), Gasdaska; John R. (Carrboro, NC), Cox; Kevin M. (Raleigh, NC), Peele; Charles G. (Apex, NC), Spencer; David (Chapel Hill, NC)
Assignee:	Biolex Therapeutics, Inc. (Durham, NC)
Application Number:	10/794,615
Patent Claims:	1. A method of producing a recombinant monoclonal antibody having effector function in a duckweed plant culture or a duckweed nodule culture, comprising the steps of: (a) culturing within a duckweed culture medium a duckweed plant culture or a duckweed nodule culture, wherein said duckweed plant culture or said duckweed nodule culture is stably transformed to express said monoclonal antibody, and wherein said monoclonal antibody is expressed from one or more nucleotide sequences comprising a coding sequence for a chain of the monoclonal antibody, an operably linked coding sequence for a signal peptide that directs secretion of the monoclonal antibody, an operably linked 5' leader sequence consisting of SEQ ID NO:16, and an operably linked plant intron sequence that is inserted upstream of the coding sequence; and (b) collecting said monoclonal antibody from the duckweed culture medium, the duckweed plant culture, or the duckweed nodule culture, wherein said coding sequence for the chain of the monoclonal antibody comprises between 70-100% Lemna gibba-preferred codons or Lemna minor-preferred codons. 2. The method according to claim 1, wherein said one or more nucleotide sequences further comprises a translation initiation codon that is flanked by a plant-preferred translation initiation context nucleotide sequence. 3. The method according to claim 1, wherein said plant intron sequence is SEQ ID NO:1. 4. The method according to claim 1, wherein a heavy chain and light chain of the monoclonal antibody are expressed and assembled in said duckweed plant culture or said duckweed nodule culture. 5. The method according to claim 1, wherein the monoclonal antibody is a human antibody. 6. The method of producing a recombinant monoclonal antibody having effector function in a duckweed plant culture or a duckweed nodule culture according to claim 1, wherein said duckweed plant culture or said duckweed nodule culture has not been genetically modified to alter glycosylation of the recombinant monoclonal antibody. 7. The method according to claim 1, wherein said coding sequence for the signal peptide comprises between 70-100% Lemna gibba-preferred codons or Lemna minor-preferred codons. 8. The method according to claim 1, wherein said signal peptide sequence is SEQ ID NO:6. 9. The method according to claim 2, wherein said plant-preferred translation initiation context nucleotide sequence consists of "ACC" or "ACA", wherein said context nucleotide sequence is positioned immediately adjacent to the 5' end of the translation initiation codon.

Details for Patent 7,632,983

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2020-07-31
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2020-07-31
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2020-07-31